Jack John Bailey Jr - President and CEO, G1 Therapeutics, Inc

As of January 5, 2021


Jack John Bailey Jr Net Worth

  • Net worth is estimated to be at least $113.6K
  • Owns at least 8,000 units of G1 Therapeutics, Inc stock

Jack John Bailey Jr Trading

  • Largest purchase of shares was 8,000 units , worth over $102.37K on November 13, 2020
  • In total has made about 4 transactions over a year
  • Usually trades in March, November, January and June, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jack John Bailey Jr Mailing Address

  • Mailing address is C/o G1 Therapeutics, Inc. 700 Park Offices Drive, Suite 200 Research Triangle Park NC 27709 NC

G1 Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John E. Bailey, Jr. 2020 - $542,109 - $215,948 $758,057
Mark A. Velleca, M.D., Ph.D. 2020 $608,308 $3,069,704 $305,000 $8,550 $3,991,562
Mark A. Velleca, M.D., Ph.D. 2019 $589,700 $3,105,237 $280,108 $8,400 $3,983,445
Mark A. Velleca, M.D., Ph.D. 2018 $515,000 $1,044,529 $321,875 $33,250 $1,914,654
Jennifer K. Moses 2020 $398,583 $1,116,239 $141,050 $8,550 $1,664,422
Jennifer K. Moses 2019 $315,598 $972,601 $117,600 $8,400 $1,414,199
Mark Avagliano 2020 $431,417 $837,165 $151,200 $18,445 $1,438,227
Mark Avagliano 2019 $181,913 $5,100,560 $142,800 $53,117 $5,478,390
Rajesh K. Malik, M.D. 2020 $424,000 $836,733 $148,750 $8,550 $1,418,033
Rajesh K. Malik, M.D. 2019 $413,000 $828,195 $138,768 $8,400 $1,388,363
Rajesh K. Malik, M.D. 2018 $400,000 $696,968 $169,400 $8,250 $1,274,618
Soma Gupta 2020 $320,360 $2,212,758 $114,662 $100,000 $2,747,780
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm

G1 Therapeutics, Inc Insider Trading

  • The most recent transaction was 30,000 units sold on July 15, 2021 by Mark Velleca worth over $570.26K
  • In the last 4 years, insiders at G1 Therapeutics, Inc sold an estimated value of $67.24M and bought an estimated value of $25.69M
  • The most active traders are Rajesh Malik, Chief Medical Officer,  Mark Velleca,  and Jennifer Moses, CFO
  • Insider trading is most common in June, with the busiest year in 2018

G1 Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1